Table II.
Result from Metabolic Pathway Analysis with MetaboAnalyst3.0.
| Pathway name | Total cmpd | Hits | Raw P-value | -log(p) | Impact |
|---|---|---|---|---|---|
| Phenylalanine, tyrosine and tryptophan biosynthesis | 4 | 2 | 1.23×10−7 | 15.914 | 1.0000 |
| Linoleic acid metabolism | 6 | 1 | 1.22×10−6 | 13.621 | 1.0000 |
| Valine, leucine and isoleucine biosynthesis | 11 | 2 | 1.46×10−6 | 13.437 | 0.6667 |
| Taurine and hypotaurine metabolism | 8 | 1 | 9.70×10−9 | 18.451 | 0.4286 |
| Phenylalanine metabolism | 11 | 2 | 1.23×10−7 | 15.914 | 0.4074 |
| Arachidonic acid metabolism | 36 | 2 | 2.76×10−3 | 5.893 | 0.3260 |
| Glyoxylate and dicarboxylate metabolism | 18 | 1 | 6.92×10−8 | 16.487 | 0.2581 |
| Tyrosine metabolism | 44 | 1 | 4.65×10−8 | 16.883 | 0.1405 |
| Citrate cycle | 20 | 2 | 2.06×10−18 | 40.726 | 0.0792 |
Total cmpd is the total number of compounds (cmpd) in the pathway; the hits is matched number from the user uploaded data; the raw P-value is the original P-value calculated from the enrichment analysis; the impact is the pathway impact value calculated from pathway topology analysis.